Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial

Guoying Liu, Yan‐Qun Xiang, Yao-Fei Jiang et al.|BMJ|2024

Cited by 17